Kavain Hydroxylation in Kava Metabolism: Computational Analysis
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5419Keywords:
kavain, hydroxylation, Kava, metabolism, intermediates, 12-hydroxykavain, hepatotoxicity, mechanism, pathwayAbstract
Kava, a non-alcoholic beverage derived from the Piper methysticum plant, commonly also known as Kava, has a prominent role in the cultures of Oceania due to its calming and soothing effects. These psychoactive properties have sparked interest beyond Oceania and in the scientific community, who see potential for medicinal applications. However, alongside these beneficial effects, consumption of Kava has been linked to potential hepatotoxicity, raising safety concerns. Understanding the cause of this hepatotoxicity requires a detailed exploration of Kava's metabolic processes, specifically those involving kavain, its primary constituent. Recent studies have found the hydroxylation of kavain to 12-hydroxykavain as a key step in Kava's metabolic pathway. Yet, the precise mechanism of this conversion and the hydroxylation intermediates involved remain poorly understood. To address this knowledge gap, our study employed Spartan, a computational chemistry software, to model the hydroxylation process. We analyzed the stability and chemical properties of the proposed reaction intermediates, providing a detailed view of this critical phase of metabolism. Our analysis reveals that three of the five proposed intermediates appear stable, suggesting they may play significant roles in the hydroxylation process. This finding also enabled us to narrow down the possible reaction pathways of hydroxylation. Having a better understanding of the key step of Kava metabolism could guide the development of safer, more effective Kava-based products, balancing the therapeutic potential of Kava with a reduced risk profile.
Downloads
References or Bibliography
Singh, Y. N. (1992). Kava: An overview. Journal of Ethnopharmacology, 37(1), 13–45. https://doi.org/10.1016/0378-8741(92)90003-A
Chua, H. C., Christensen, E. T. H., Hoestgaard-Jensen, K., Hartiadi, L. Y., Ramzan, I., Jensen, A. A., Absalom, N. L., & Chebib, M. (2016). Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism. PLOS ONE, 11(6), e0157700. https://doi.org/10.1371/journal.pone.0157700
Tarbah, F. A. (2004). Analytical studies on the kavain metabolism in human specimens and liver cell lines.
Lebot, V., & Lèvesque, J. (1989). THE ORIGIN AND DISTRIBUTION OF KAVA (PIPER METHYSTICUM FORST. F., PIPERACEAE): A PHYTOCHEMICAL APPROACH. Allertonia, 5(2), 223–281. JSTOR.
Builders, P. F. (Ed.). (2019). Herbal Medicine. IntechOpen.
Soares, R. B., Dinis-Oliveira, R. J., & Oliveira, N. G. (2022). An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine, 11(14), 4039. https://doi.org/10.3390/jcm11144039
Freeman, B., Mamallapalli, J., Bian, T., Ballas, K., Lynch, A., Scala, A., Huo, Z., Fredenburg, K. M., Bruijnzeel, A. W., Baglole, C. J., Lu, J., Salloum, R. G., Malaty, J., & Xing, C. (2023). Opportunities and Challenges of Kava in Lung Cancer Prevention. International Journal of Molecular Sciences, 24(11), 9539. https://doi.org/10.3390/ijms24119539
Geier, F. P., & Konstantinowicz, T. (2004). Kava treatment in patients with anxiety. Phytotherapy Research, 18(4), 297–300. https://doi.org/10.1002/ptr.1422
Wheatley, D. (2001). Kava and Valerian in the treatment of stress-induced insomnia. Phytotherapy Research, 15(6), 549–551. https://doi.org/10.1002/ptr.840
Fu, P. P., Xia, Q., Guo, L., Yu, H., & Chan, P.-C. (2008). Toxicity of Kava Kava. Journal of Environmental Science and Health, Part C, 26(1), 89–112. https://doi.org/10.1080/10590500801907407
Humberston, C. L., Akhtar, J., & Krenzelok, E. P. (2003). Acute Hepatitis Induced by Kava Kava: ARTICLE. Journal of Toxicology: Clinical Toxicology, 41(2), 109–113. https://doi.org/10.1081/CLT-120019123
Tarbah, F., Mahler, H., Kardel, B., Weinmann, W., Hafner, D., & Daldrup, T. (2003). Kinetics of kavain and its metabolites after oral application. Journal of Chromatography B, 789(1), 115–130. https://doi.org/10.1016/S1570-0232(03)00046-1
Cairney, S., Maruff, P., & Clough, A. R. (2002). The Neurobehavioural Effects of Kava. Australian & New Zealand Journal of Psychiatry, 36(5), 657–662. https://doi.org/10.1046/j.1440-1614.2002.01027.x
Köppel, C., & Tenczer, J. (1991). Mass spectral characterization of urinary metabolites of d,l-kawain. Journal of Chromatography B: Biomedical Sciences and Applications, 562(1–2), 207–211. https://doi.org/10.1016/0378-4347(91)80578-Z
Duffield, A. M., Jamieson, D. D., Lidgard, R. O., Duffield, P. H., & Bourne, D. J. (1989). Identification of some human urinary metabolites of the intoxicating beverage kava. Journal of Chromatography A, 475(2), 273–281. https://doi.org/10.1016/S0021-9673(01)89682-5
Rasmussen, A. K., Scheline, R. R., Solheim, E., & Hänsel, R. (1979). Metabolism of Some Kava Pyrones in the Rat. Xenobiotica, 9(1), 1–16. https://doi.org/10.3109/00498257909034699
Wang, P., Zhu, J., Shehu, A. I., Lu, J., Chen, J., Zhong, X., & Ma, X. (2019). Enzymes and Pathways of Kavain Bioactivation and Biotransformation. Chemical Research in Toxicology, 32(7), 1335–1342. https://doi.org/10.1021/acs.chemrestox.9b00098
Trager, W. F. (2007). Principles of Drug Metabolism 1: Redox Reactions. In Comprehensive Medicinal Chemistry II (pp. 87–132). Elsevier. https://doi.org/10.1016/B0-08-045044-X/00119-X
Bathelt, C. M., Ridder, L., Mulholland, A. J., & Harvey, J. N. (2004). Mechanism and structure–reactivity relationships for aromatic hydroxylation by cytochrome P450. Org. Biomol. Chem., 2(20), 2998–3005. https://doi.org/10.1039/B410729B
National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 11963739, Iron(5+);porphyrin-22,24-diide. Retrieved July 30, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/11963739.
Wavefunction Inc. (2011). Spartan 10 Tutorial and User’s Guide for Windows, Macintosh, and Linux. Retrieved from https://downloads.wavefun.com/Spartan16Manual.pdf
Published
How to Cite
Issue
Section
Copyright (c) 2023 Youlin Feng
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.